The biggest trend in medicine is early detection. Using a mix of more advanced (and cheaper) genetic analysis and technology that can find symptoms sooner, earlier treatments are becoming a larger focus for the medical world. The global preventive medicine market’s value is hard to estimate, but it has tremendous implications for diagnosing early-stage cancer.
Last week, Professor Hasson Haick’s research team at the Technion in Haifa, Israel made the 2015 Nominet Trust 100 list (NT100). It includes 100 different hi-tech projects projected to make a major difference in the world.
